Diligence memo · auto-generated · as of July 2, 2026

R3 Vascular Inc.

R3 Vascular Inc. looks fair against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 27.2× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

R3 Vascular Inc. operates in Other Health Care, based in Mountain View.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

R3 Vascular Inc. has raised $75M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $72M on 2024-04-26.

Most recent recorded round closed around 2024-04-26.

Valuation (modeled)modeled

Provath models R3 Vascular Inc. at approximately $621M (range $264M–$968M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.95× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era. Within the normal band (95% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 56 months.

Last raise 2.2 yr ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 27.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 95% of Other Health Care peers (5377 compared).

Modeled value ranks above 94% of those peers.

Closest niche peers: Gravie, Inc., EmpowerMe Holdings, LLC, Color Holdings, L.P., RSR Senior Residences, LLC, Gynesonics, Inc.

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.